- Home
- NUTX vs SEER Comparison
NUTX vs SEER Comparison
Compare NUTX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUTX | SEER |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.5M | 98.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NUTX | SEER |
|---|---|---|
| Price | $175.91 | $1.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $252.50 | N/A |
| AVG Volume (30 Days) | ★ 225.2K | 179.8K |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 17.98 | N/A |
| Revenue | ★ $981,195,633.00 | $16,376,999.00 |
| Revenue This Year | $104.36 | $22.37 |
| Revenue Next Year | $4.10 | $30.00 |
| P/E Ratio | $10.29 | ★ N/A |
| Revenue Growth | ★ 236.03 | 12.11 |
| 52 Week Low | $28.12 | $1.62 |
| 52 Week High | $193.00 | $2.52 |
Technical Indicators
Market Signals| Indicator | NUTX | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 62.60 | 37.05 |
| Support Level | $107.09 | $1.76 |
| Resistance Level | $193.00 | $2.02 |
| Average True Range (ATR) | 16.42 | 0.08 |
| MACD | 4.66 | -0.00 |
| Stochastic Oscillator | 78.56 | 31.37 |
Price Performance
Historical ComparisonAbout NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.